HARVARD BIOSCIENCE INC (HBIO)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenues | 20,450 | 21,774 | 21,970 | 23,097 |
| Cost of revenues | 8,917 | 9,590 | 9,205 | 9,879 |
| Gross profit | 11,533 | 12,184 | 12,765 | 13,218 |
| Sales and marketing expenses | 4,539 | 4,971 | 5,518 | 5,395 |
| Research and development expenses | 2,189 | 2,321 | 2,567 | 2,626 |
| Other operating expenses - note 1 | 200 | 264 | 179 | 249 |
| Goodwill impairment - note 4 | - | 47,951 | - | - |
| General and administrative expenses | 4,262 | 5,185 | 5,041 | 5,686 |
| Amortization of acquired intangible assets | 1,162 | 1,160 | 1,334 | 1,331 |
| Total operating expenses | 12,352 | 61,852 | 14,639 | 15,287 |
| Operating loss | -819 | -49,668 | -1,874 | -2,069 |
| Loss on pension settlement - note 16 | - | - | 1,243 | - |
| Other expense, net | -644 | -324 | -518 | -181 |
| Interest expense | -791 | -802 | -856 | -749 |
| Loss on equity securities - note 6 | - | - | - | -281 |
| Total other expense | -1,435 | -1,126 | -2,617 | -1,211 |
| Loss before income taxes | -2,254 | -50,794 | -4,491 | -3,280 |
| Income tax (benefit) expense | 28 | -454 | 311 | -353 |
| Net loss | -2,282 | -50,340 | -4,802 | -2,927 |
| Basic loss per share (in dollars per share) | -0.05 | -1.14 | -0.11 | -0.07 |
| Diluted loss per share (in dollars per share) | -0.05 | -1.14 | -0.11 | -0.07 |
| Us-gaap_weightedaveragenumberofdilutedsharesoutstanding | 44,303,000 | 44,096,000 | 43,614,000 | 43,486,000 |
| Weighted average shares outstanding - basic (in shares) | 44,303,000 | 44,096,000 | 43,614,000 | 43,486,000 |